Cargando…
Quality of life in lung cancer survivors treated with tyrosine-kinase inhibitors (TKI): results from the multi-centre cross-sectional German study LARIS
PURPOSE: We aimed at exploring the quality of life (QOL) of lung cancer survivors with proven tyrosine-kinase receptor (RTK) genetic alterations and targeted tyrosine-kinase inhibitors (TKI) therapy, compared to lung cancer survivors with no-RTK alterations and no-TKI therapy. METHODS: Data were col...
Autores principales: | Riccetti, Nicola, Blettner, Maria, Taylor, Katherine, Wehler, Beatrice, Gohrbandt, Bernhard, Nestle, Ursula, Bals, Robert, Stockinger, Marcus, Wehler, Thomas, Singer, Susanne, Eichler, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293811/ https://www.ncbi.nlm.nih.gov/pubmed/35608689 http://dx.doi.org/10.1007/s00432-022-03975-6 |
Ejemplares similares
-
Returning to work in lung cancer survivors—a multi-center cross-sectional study in Germany
por: Rashid, Humayra, et al.
Publicado: (2020) -
Comparative Genomics of the Campylobacter lari Group
por: Miller, William G., et al.
Publicado: (2014) -
The ISOLDE RILIS pump laser upgrade and the LARIS Laboratory
por: Marsh, B A, et al.
Publicado: (2010) -
Genome Sequence of a Urease-Positive Campylobacter lari Strain
por: Meinersmann, Richard J., et al.
Publicado: (2015) -
Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease
por: Hoffknecht, Petra, et al.
Publicado: (2015)